1,052
Participants
Start Date
October 31, 2025
Primary Completion Date
January 1, 2027
Study Completion Date
January 1, 2028
Early intervention
"In this arm, patient will receive unique dose of the PCV-20 vaccine (Prevnar 20) as soon as possible and until 72h after apyrexia.~The Prevenar 20 will be used Prevenar 20 will be injected by intramuscular route. The preferred site of injection is the deltoid muscle of the upper arm in adults."
Delayed intervention
"In this arm, from 15 days and until 58 days after fever resolution (i.e after the first day with a body temperature \< 37.5°C without paracetamol use in the 6 previous hours) (whether or not the patient has been discharged) in the absence of fever, the patient will receive unique dose of the PCV-20 vaccine (Prevnar 20).~The Prevenar 20 will be used Prevenar 20 will be injected by intramuscular route. The preferred site of injection is the deltoid muscle of the upper arm in adults."
Centre Hospitalier Universitaire, Dijon
Centre Hospitalier Universitaire, Besançon
Centre Hospitalier Universitaire, Brest
Centre Hospitalier, Brest
Centre Hospitalier Universitaire, Nîmes
Centre Hospitalier, Bordeaux
Centre Hospitalier Regional Universitaire, Montpellier
Centre Hospitalier Universitaire, Rennes
Centre Hospitalier Universitaire, Grenoble
CHU de Saint-Etienne, Saint-Etienne
Centre Hospitalier, Le Puy-en-Velay
Centre Hospitalier Universitaire, Nantes
Centre Hospitalier Universitaire, Nancy
Centre Hospitalier Universitaire, Lille
Hospices Civils de Lyon, Lyon
Centre Hospitalier General, Le Mans
Centre Hospitalier General Metropole Savoie, Chambéry
Centre Hospitalier, Annecy
Centre Hospitalier Bichat, Paris
Assistance Publique Hopitaux de Paris, Paris
Centre Hospitalier Universitaire, Rouen
Centre Hospitalier, La Roche-sur-Yon
Centre Hospitalier de Creteil, Créteil
Centre Hospitalier Universitaire, Nice
Ministry of Health, France
OTHER_GOV
Centre Hospitalier Universitaire de Saint Etienne
OTHER